Dcyd Mediated Protection of Myeloid Progenitor Cells

Bhalla, Kapil N.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29CA045671-02
• Application #: 3458495
• Study Section: Experimental Therapeutics Subcommittee 2 (ET)
• Project Start: 1988-02-01
• Project End: 1989-06-30
• Budget Start: 1989-02-01
• Budget End: 1989-06-30
• Support Year: 2
• Fiscal Year: 1989

Institution

• Name: Columbia University (N.Y.)
• Type: Schools of Medicine
• DUNS #: 064931884
• City: New York
• State: NY
• Country: United States
• Zip Code: 10027

Publications

Bhalla, K; Birkhofer, M; Arlin, Z et al. (1991) Differential effect of interleukin 3 on the metabolism of high-dose cytosine arabinoside in normal versus leukemic human bone marrow cells. Exp Hematol 19:669-73

Bhalla, K; Swerdlow, P; Grant, S (1991) Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells. Blood 78:2937-44

Bhalla, K; Holladay, C; Arlin, Z et al. (1991) Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts. Blood 78:2674-9

Bhalla, K; Birkhofer, M; Grant, S et al. (1989) The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Exp Hematol 17:17-20

Bhalla, K; Birkhofer, M; Arlin, Z et al. (1988) Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells. Leukemia 2:810-3